Biomarker Discovery Outsourcing Services Market Size, Share, Trends, Industry Analysis Report: By Type, Therapeutic Area, Discovery Phase, End Use, and Region

Description

List of Tables

The global biomarker discovery outsourcing services market size is expected to reach USD 83.93 billion by 2034, according to a new study by Polaris Market Research. The report "Biomarker Discovery Outsourcing Services Market Size, Share, Trends, Industry Analysis Report: By Type (Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers, and Surrogate Endpoints), Therapeutic Area, Discovery Phase, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Biomarker discovery outsourcing services involve contracting third-party organizations to identify, validate, and develop biomarkers that play a crucial role in disease diagnosis, drug development, and personalized medicine. These services are offered by contract research organizations (CROs), biotechnology firms, and specialized laboratories, providing pharmaceutical and healthcare companies access to advanced technologies such as next-generation sequencing, proteomics, and bioinformatics. By outsourcing biomarker discovery, companies can optimize research and development (R&D) efficiency, reduce operational costs, and accelerate the time-to-market for new therapies. The growing focus on precision medicine and targeted therapies has significantly increased the demand for these services, as biomarkers help in identifying patient-specific responses to treatments and improving clinical trial success rates. The biomarker discovery outsourcing services market is witnessing steady growth due to increasing research collaborations, rising healthcare investments, and advancements in biomarker-based diagnostics.

The biomarker discovery outsourcing services market is experiencing significant growth, fueled by advancements in technology, a robust pharmaceutical sector, and supportive regulatory frameworks. Key drivers include the increasing adoption of artificial intelligence (AI) and machine learning to enhance biomarker analysis, as well as the expansion of service portfolios to meet diverse research needs. Companies are also prioritizing strategic collaborations with drug developers to improve efficiency and competitiveness. The rising focus on personalized medicine and biomarker-driven drug development is further accelerating market expansion, creating opportunities for innovative solutions in disease detection and treatment optimization. As demand for precision medicine grows, the market is poised for continued progress, offering cutting-edge tools and services to advance biomedical research and therapeutic development.

Biomarker Discovery Outsourcing Services Market Report Highlights

By type, surrogate endpoints hold the largest market share. Surrogate endpoints serve as indirect measures representing clinical outcomes, enabling researchers to assess treatment efficacy and safety more efficiently during drug development.

By therapeutic area, oncology dominates the biomarker discovery outsourcing services market, driven by the increasing prevalence of cancer and the growing adoption of biomarker-driven drug development. The use of biomarkers in early cancer detection, prognosis, and treatment selection enhances the segment's significance in clinical research.

North America holds the largest market share. This dominance is driven by substantial R&D investments, a strong emphasis on precision medicine, and robust collaborations between pharmaceutical companies and contract research organizations (CROs).

Asia Pacific is experiencing the highest biomarker discovery outsourcing services market CAGR. This rapid expansion is attributed to increasing pharmaceutical R&D activities, a surge in clinical trial operations, and cost-effective outsourcing solutions available in countries such as China and India.

The biomarker discovery outsourcing services market key players include Laboratory Corporation of America Holdings (Labcorp), Charles River Laboratories International, Inc., Eurofins Scientific, Celerion, ICON plc, Parexel International (MA) Corporation, Proteome Sciences, Thermo Fisher Scientific Inc., Evotec, WuXi AppTec, GenScript ProBio, and Fujirebio Holdings Inc

Polaris Market Research has segmented biomarker discovery outsourcing services market report based on type, therapeutic area, discovery phase, end use, and region:

By Type Outlook (Revenue-USD Billion, 2020-2034)

Predictive Biomarkers

Prognostic Biomarkers

Safety Biomarkers

Surrogate Endpoints

By Therapeutic Area Outlook (Revenue-USD Billion, 2020-2034)

Oncology

Neurology

Cardiology

Autoimmune Diseases

Others

By Discovery Phase Outlook (Revenue-USD Billion, 2020-2034)

Biomarker Identification

Biomarker Validation

Biomarker Profiling

Biomarker Panel Development

Biomarker Selection

By End Use Outlook (Revenue-USD Billion, 2020-2034)

Pharmaceutical Companies

Biotechnology Companies

Others

By Regional Outlook (Revenue-USD Billion, 2020-2034)

North America

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

Suth Korea

Indnesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

Suth Africa

Rest of Middle East & Africa

Latin America

Mexic

Brazil

Argentina

Rest of Latin America

Product Code: PM4075

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Biomarker Discovery Outsourcing Services Market Insights

4.1. Biomarker Discovery Outsourcing Services Market - Market Snapshot
4.2. Biomarker Discovery Outsourcing Services Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Prevalence of Chronic Diseases
  - 4.2.1.2. Advancements in Omics Technologies
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High cost and complexity of biomarker validation
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Biomarker Discovery Outsourcing Services Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Biomarker Discovery Outsourcing Services Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
5.3. Predictive biomarkers
- 5.3.1. Global Biomarker Discovery Outsourcing Services Market, by Predictive biomarkers, by Region, 2020-2034 (USD Billion)
5.4. Prognostic biomarkers
- 5.4.1. Global Biomarker Discovery Outsourcing Services Market, by Prognostic biomarkers, by Region, 2020-2034 (USD Billion)
5.5. Safety biomarkers
- 5.5.1. Global Biomarker Discovery Outsourcing Services Market, by Safety biomarkers, by Region, 2020-2034 (USD Billion)
5.6. Surrogate endpoints
- 5.6.1. Global Biomarker Discovery Outsourcing Services Market, by Surrogate endpoints, by Region, 2020-2034 (USD Billion)

6. Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
6.3. Oncology
- 6.3.1. Global Biomarker Discovery Outsourcing Services Market, by Oncology, by Region, 2020-2034 (USD Billion)
6.4. Neurology
- 6.4.1. Global Biomarker Discovery Outsourcing Services Market, by Neurology, by Region, 2020-2034 (USD Billion)
6.5. Cardiology
- 6.5.1. Global Biomarker Discovery Outsourcing Services Market, by Cardiology, by Region, 2020-2034 (USD Billion)
6.6. Autoimmune Diseases
- 6.6.1. Global Biomarker Discovery Outsourcing Services Market, by Autoimmune Diseases, by Region, 2020-2034 (USD Billion)
6.7. Others
- 6.7.1. Global Biomarker Discovery Outsourcing Services Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
7.3. Biomarker Identification
- 7.3.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Identification, by Region, 2020-2034 (USD Billion)
7.4. Biomarker Validation
- 7.4.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Validation, by Region, 2020-2034 (USD Billion)
7.5. Biomarker Profiling
- 7.5.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Profiling, by Region, 2020-2034 (USD Billion)
7.6. Biomarker Panel Development
- 7.6.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Panel Development, by Region, 2020-2034 (USD Billion)
7.7. Biomarker Selection
- 7.7.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Selection, by Region, 2020-2034 (USD Billion)

8. Global Biomarker Discovery Outsourcing Services Market, by End Use

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
8.3. Pharmaceutical Companies
- 8.3.1. Global Biomarker Discovery Outsourcing Services Market, by Pharmaceutical Companies, by Region, 2020-2034 (USD Billion)
8.4. Biotechnology Companies
- 8.4.1. Global Biomarker Discovery Outsourcing Services Market, by Biotechnology Companies, by Region, 2020-2034 (USD Billion)
8.5. Others
- 8.5.1. Global Biomarker Discovery Outsourcing Services Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Biomarker Discovery Outsourcing Services Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. Biomarker Discovery Outsourcing Services Market Assessment, By Geography, 2020-2034 (USD Billion)
9.3. Biomarker Discovery Outsourcing Services Market - North America
- 9.3.1. North America: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.3.2. North America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.3.3. North America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.3.4. North America: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.3.5. Biomarker Discovery Outsourcing Services Market - US
  - 9.3.5.1. US: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  - 9.3.5.2. US: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 9.3.5.3. US: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  - 9.3.5.4. US: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.3.6. Biomarker Discovery Outsourcing Services Market - Canada
  - 9.3.6.1. Canada: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  - 9.3.6.2. Canada: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 9.3.6.3. Canada: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  - 9.3.6.4. Canada: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
9.4. Biomarker Discovery Outsourcing Services Market - Europe
- 9.4.1. Europe: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.4.2. Europe: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.4.3. Europe: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.4.4. Europe: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.4.5. Biomarker Discovery Outsourcing Services Market - UK
  - 9.4.5.1. UK: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  - 9.4.5.2. UK: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 9.4.5.3. UK: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  - 9.4.5.4. UK: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.4.6. Biomarker Discovery Outsourcing Services Market - France
  - 9.4.6.1. France: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  - 9.4.6.2. France: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 9.4.6.3. France: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  - 9.4.6.4. France: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.4.7. Biomarker Discovery Outsourcing Services Market - Germany
  - 9.4.7.1. Germany: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  - 9.4.7.2. Germany: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 9.4.7.3. Germany: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  - 9.4.7.4. Germany: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.4.8. Biomarker Discovery Outsourcing Services Market - Italy
  - 9.4.8.1. Italy: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  - 9.4.8.2. Italy: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 9.4.8.3. Italy: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  - 9.4.8.4. Italy: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.4.9. Biomarker Discovery Outsourcing Services Market - Spain
  - 9.4.9.1. Spain: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  - 9.4.9.2. Spain: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 9.4.9.3. Spain: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  - 9.4.9.4. Spain: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.4.10. Biomarker Discovery Outsourcing Services Market - Netherlands
  - 9.4.10.1. Netherlands: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  - 9.4.10.2. Netherlands: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 9.4.10.3. Netherlands: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  - 9.4.10.4. Netherlands: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.4.11. Biomarker Discovery Outsourcing Services Market - Russia
  - 9.4.11.1. Russia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  - 9.4.11.2. Russia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 9.4.11.3. Russia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  - 9.4.11.4. Russia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.4.12. Biomarker Discovery Outsourcing Services Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  - 9.4.12.2. Rest of Europe: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 9.4.12.3. Rest of Europe: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  - 9.4.12.4. Rest of Europe: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
9.5. Biomarker Discovery Outsourcing Services Market - Asia Pacific
- 9.5.1. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.5.2. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.5.3. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.5.4. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.5.5. Biomarker Discovery Outsourcing Services Market - China
  - 9.5.5.1. China: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  - 9.5.5.2. China: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 9.5.5.3. China: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  - 9.5.5.4. China: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.5.6. Biomarker Discovery Outsourcing Services Market - India
  - 9.5.6.1. India: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  - 9.5.6.2. India: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 9.5.6.3. India: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  - 9.5.6.4. India: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.5.7. Biomarker Discovery Outsourcing Services Market - Malaysia
  - 9.5.7.1. Malaysia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  - 9.5.7.2. Malaysia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 9.5.7.3. Malaysia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  - 9.5.7.4. Malaysia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.5.8. Biomarker Discovery Outsourcing Services Market - Japan
  - 9.5.8.1. Japan: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  - 9.5.8.2. Japan: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 9.5.8.3. Japan: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  - 9.5.8.4. Japan: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.5.9. Biomarker Discovery Outsourcing Services Market - Indonesia
  - 9.5.9.1. Indonesia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  - 9.5.9.2. Indonesia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 9.5.9.3. Indonesia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  - 9.5.9.4. Indonesia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.5.10. Biomarker Discovery Outsourcing Services Market - South Korea
  - 9.5.10.1. South Korea: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  - 9.5.10.2. South Korea: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 9.5.10.3. South Korea: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  - 9.5.10.4. South Korea: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.5.11. Biomarker Discovery Outsourcing Services Market - Australia
  - 9.5.11.1. Australia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  - 9.5.11.2. Australia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 9.5.11.3. Australia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  - 9.5.11.4. Australia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.5.12. Biomarker Discovery Outsourcing Services Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  - 9.5.12.2. Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 9.5.12.3. Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  - 9.5.12.4. Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
9.6. Biomarker Discovery Outsourcing Services Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.6.2. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.6.3. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.6.4. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.6.5. Biomarker Discovery Outsourcing Services Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  - 9.6.5.2. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 9.6.5.3. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  - 9.6.5.4. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.6.6. Biomarker Discovery Outsourcing Services Market - UAE
  - 9.6.6.1. UAE: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  - 9.6.6.2. UAE: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 9.6.6.3. UAE: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  - 9.6.6.4. UAE: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.6.7. Biomarker Discovery Outsourcing Services Market - Israel
  - 9.6.7.1. Israel: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  - 9.6.7.2. Israel: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 9.6.7.3. Israel: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  - 9.6.7.4. Israel: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.6.8. Biomarker Discovery Outsourcing Services Market - South Africa
  - 9.6.8.1. South Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  - 9.6.8.2. South Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 9.6.8.3. South Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  - 9.6.8.4. South Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.6.9. Biomarker Discovery Outsourcing Services Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  - 9.6.9.2. Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 9.6.9.3. Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  - 9.6.9.4. Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
9.7. Biomarker Discovery Outsourcing Services Market - Latin America
- 9.7.1. Latin America: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
- 9.7.2. Latin America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 9.7.3. Latin America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
- 9.7.4. Latin America: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.7.5. Biomarker Discovery Outsourcing Services Market - Mexico
  - 9.7.5.1. Mexico: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  - 9.7.5.2. Mexico: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 9.7.5.3. Mexico: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  - 9.7.5.4. Mexico: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.7.6. Biomarker Discovery Outsourcing Services Market - Brazil
  - 9.7.6.1. Brazil: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  - 9.7.6.2. Brazil: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 9.7.6.3. Brazil: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  - 9.7.6.4. Brazil: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.7.7. Biomarker Discovery Outsourcing Services Market - Argentina
  - 9.7.7.1. Argentina: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  - 9.7.7.2. Argentina: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 9.7.7.3. Argentina: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  - 9.7.7.4. Argentina: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
- 9.7.8. Biomarker Discovery Outsourcing Services Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  - 9.7.8.2. Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 9.7.8.3. Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  - 9.7.8.4. Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Celerion
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Charles River Laboratories International, Inc.
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Eurofins Scientific
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. Evotec
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. Fujirebio Holdings Inc.
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. GenScript ProBio
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. ICON plc
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. Laboratory Corporation of America Holdings (Labcorp)
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Parexel International (MA) Corporation
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Proteome Sciences
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. Thermo Fisher Scientific Inc.
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
11.12. WuXi AppTec
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development